AltMountain

Blackstone Life Sciences IV-V Ferring, L.P.

New York, NY · CIK 1796300
Status: no Form D since Dec 2019. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

Blackstone Life Sciences IV-V Ferring, L.P. is a private equity fund based in New York, New York. Its most recent Form D, filed Dec 9, 2019, reports no sales yet. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Matthew Skurbe; Christopher Striano; Omar Rehman.

Total raised
$0Cumulative sales reported on Form D
Investors
0
First sale
—
Minimum investment
None set
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Matthew Skurbe; Christopher Striano; Omar Rehman
Latest Form D
Dec 9, 2019

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌‌​​​​​​​​​​⁠

Questions about Blackstone Life Sciences IV-V Ferring, L.P.

What is the minimum investment for Blackstone Life Sciences IV-V Ferring, L.P.?

Blackstone Life Sciences IV-V Ferring, L.P.'s latest Form D, filed Dec 9, 2019, does not set a minimum investment. Managers can still require one in the offering documents.

Who can invest in Blackstone Life Sciences IV-V Ferring, L.P.?

Blackstone Life Sciences IV-V Ferring, L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.

How much has Blackstone Life Sciences IV-V Ferring, L.P. raised?

Blackstone Life Sciences IV-V Ferring, L.P.'s latest Form D, filed Dec 9, 2019, reports no sales yet.

Where is Blackstone Life Sciences IV-V Ferring, L.P. based?

Blackstone Life Sciences IV-V Ferring, L.P. is based in New York, New York.

Size compared with every private equity fund

This fund hasn't reported any sales yet.

Other funds with the same team

More private equity funds in New York

Recently filed private equity funds in New York

All private equity funds in New York